Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders

Translational Psychiatry

Volumn 5, Issue 2, 2015, Pages

  Cathomas, F ^a,b   Stegen, M ^c   Sigrist, H ^a   Schmid, L ^a   Seifritz, E ^b,d   Gassmann, M ^c   Bettler, B ^c   Pryce, C R ^a,d  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; KCTD12 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; PFETIN PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY STIMULATION; BEHAVIOR; CIRCADIAN RHYTHM; CONTROLLED STUDY; DNA POLYMORPHISM; ELECTROPHYSIOLOGICAL PROCEDURES; EMOTIONALITY; ENDOPHENOTYPE; FEMALE; GENE; GENE EXPRESSION; GENOTYPE; HETEROZYGOTE; HIPPOCAMPUS; HOT PLATE TEST; KCTD12 GENE; LOCOMOTION; MALE; MEMBRANE POTENTIAL; MEMORY; MOOD DISORDER; MOUSE; MUTANT; NERVE EXCITABILITY; NOCICEPTION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SUCROSE PREFERENCE TEST; WILD TYPE; ANIMAL; ANIMAL BEHAVIOR; EMOTION; FEAR; GENETICS; KNOCKOUT MOUSE; LEARNING; METABOLISM; MOTOR ACTIVITY;

ANIMALS; BEHAVIOR, ANIMAL; CIRCADIAN RHYTHM; EMOTIONS; FEAR; HETEROZYGOTE; HIPPOCAMPUS; LEARNING; MEMORY; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTORS, GABA;

EID: 84927722830     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2015.8     Document Type: Article

References (53)

1. Padgett CL, Slesinger PA. GABAB receptor coupling to G-proteins and ion channels. Adv Pharmacol 2010; 58: 123-147.
2. Gassmann M, Bettler B. Regulation of neuronal GABAB receptor functions by subunit composition. Nat Rev Neurosci 2012; 13: 380-394.
3. Ivankova K, Turecek R, Fritzius T, Seddik R, Prezeau L, Comps-Agrar L et al. Upregulation of GABAB receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12). J Biol Chem 2013; 288: 24848-24856.
4. Schwenk J, Metz M, Zolles G, Turecek R, Fritzius T, Bildl W et al. Native GABAB receptors are heteromultimers with a family of auxiliary subunits. Nature 2010; 465: 231-235.
5. Fatemi SH, Folsom TD, Thuras PD. Deficits in GABAB receptor system in schizophrenia and mood disorders: a postmortem study. Schizophr Res 2011; 128: 37-43.
6. Mohler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012; 62: 42-53.
7. Peters S, Slattery DA, Flor PJ, Neumann ID, Reber SO. Differential effects of baclofen and oxytocin on the increased ethanol consumption following chronic psychosocial stress in mice. Addict Biol 2013; 18: 66-77.
8. Cryan JF, Slattery DA. GABAB receptors and depression. Current status. Adv Pharmacol 2010; 58: 427-451.
9. Kumar K, Sharma S, Kumar P, Deshmukh R. Therapeutic potential of GABAB receptor ligands in drug addiction, anxiety, depression and other CNS disorders. Pharmacol Biochem Behav 2013; 110: 174-184.
10. Jacobson LH, Bettler B, Kaupmann K, Cryan JF. GABAB1 receptor subunit isoforms exert a differential influence on baseline but not GABAB receptor agonist-induced changes in mice. J Pharmacol Exp Ther 2006; 319: 1317-1326.
11. Jacobson LH, Bettler B, Kaupmann K, Cryan JF. Behavioral evaluation of mice deficient in GABAB1 receptor isoforms in tests of unconditioned anxiety. Psychopharmacology (Berl) 2007; 190: 541-553.
12. Jacobson LH, Kelly PH, Bettler B, Kaupmann K, Cryan JF. GABAB1 receptor isoforms differentially mediate the acquisition and extinction of aversive taste memories. J Neurosci 2006; 26: 8800-8803.
13. Shaban H, Humeau Y, Herry C, Cassasus G, Shigemoto R, Ciocchi S et al. Generalization of amygdala LTP and conditioned fear in the absence of presynaptic inhibition. Nat Neurosci 2006; 9: 1028-1035.
14. Lee MT, Chen CH, Lee CS, Chen CC, Chong MY, Ouyang WC et al. Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol Psychiatry 2011; 16: 548-556.
15. Miller GE, Chen E, Sze J, Marin T, Arevalo JM, Doll R et al. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NFkappaB signaling. Biol Psychiatry 2008; 64: 266-272.
16. Sibille E, Wang Y, Joeyen-Waldorf J, Gaiteri C, Surget A, Oh S et al. A molecular signature of depression in the amygdala. Am J Psychiatry 2009; 166: 1011-1024.
17. Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sasik R, Khanlou N et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci USA 2005; 102: 15533-15538.
18. Benes FM. Amygdalocortical circuitry in schizophrenia: from circuits to molecules. Neuropsychopharmacology 2010; 35: 239-257.
19. Metz M, Gassmann M, Fakler B, Schaeren-Wiemers N, Bettler B. Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain. J Comp Neurol 2011; 519: 1435-1454.
20. Turecek R, Schwenk J, Fritzius T, Ivankova K, Zolles G, Adelfinger L et al. Auxiliary GABAB receptor subunits uncouple G protein subunits from effector channels to induce desensitization. Neuron 2014; 82: 1032-1044.
21. Rihmer Z, Szadoczky E, Furedi J, Kiss K, Papp Z. Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: results from a populationbased study in Hungary. J Affect Disord 2001; 67: 175-179.
22. Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004; 161: 2222-2229.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5), 5th edn. American Psychiatric Association: Washington DC, USA, 2013.
24. Franklin KBJ, Paxinos G. The Mouse Brain: In Stereotaxic Coordinates. Elsevier: Amsterdam, The Netherlands, 2008.
25. Pryce CR, Azzinnari D, Sigrist H, Gschwind T, Lesch KP, Seifritz E. Establishing a learned-helplessness effect paradigm in C57BL/6 mice: behavioural evidence for emotional, motivational and cognitive effects of aversive uncontrollability per se. Neuropharmacology 2012; 62: 358-372.
26. LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci 2000; 23: 155-184.
27. Nissen C, Holz J, Blechert J, Feige B, Riemann D, Voderholzer U et al. Learning as a model for neural plasticity in major depression. Biol Psychiatry 2010; 68: 544-552.
28. Azzinnari D, Sigrist H, Staehli S, Palme R, Hildebrandt T, Leparc G et al. Mouse social stress induces increased fear conditioning, helplessness and fatigue to physical challenge together with markers of altered immune and dopamine function. Neuropharmacology 2014; 85: 328-341.
29. Pan BX, Dong Y, Ito W, Yanagawa Y, Shigemoto R, Morozov A. Selective gating of glutamatergic inputs to excitatory neurons of amygdala by presynaptic GABAB receptor. Neuron 2009; 61: 917-929.
30. Savitz J, Drevets WC. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev 2009; 33: 699-771.
31. Malcangio M, Malmberg-Aiello P, Giotti A, Ghelardini C, Bartolini A. Desensitization of GABAB receptors and antagonism by CGP 35348, prevent bicuculline-and picrotoxin-induced antinociception. Neuropharmacology 1992; 31: 783-791.
32. Schuler V, Luscher C, Blanchet C, Klix N, Sansig G, Klebs K et al. Epilepsy, hyperalgesia, impaired memory, and loss of pre-and postsynaptic GABAB responses in mice lacking GABAB1. Neuron 2001; 31: 47-58.
33. Nazar M, Siemiatkowski M, Czlonkowska A, Sienkiewicz-Jarosz H, Plaznik A. The role of the hippocampus and 5-HT/GABA interaction in the central effects of benzodiazepine receptor ligands. J Neural Transm 1999; 106: 369-381.
34. Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci 2010; 13: 1161-1169.
35. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 1997; 134: 319-329.
36. Goldstein SA, Bayliss DA, Kim D, Lesage F, Plant LD, Rajan S. International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol Rev 2005; 57: 527-540.
37. Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y et al. International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels. Pharmacol Rev 2005; 57: 509-526.
38. Novak CM, Ehlen JC, Huhman KL, Albers HE. GABAB receptor activation in the suprachiasmatic nucleus of diurnal and nocturnal rodents. Brain Res Bull 2004; 63: 531-535.
39. Vienne J, Bettler B, Franken P, Tafti M. Differential effects of GABAB receptor subtypes,-hydroxybutyric acid, and baclofen on EEG activity and sleep regulation. J Neurosci 2010; 30: 14194-14204.
40. Craig MT, Mayne EW, Bettler B, Paulsen O, McBain CJ. Distinct roles of GABAB1aand GABAB1b-containing GABAB receptors in spontaneous and evoked termination of persistent cortical activity. J Physiol 2013; 591: 835-843.
41. Kim DJ, Bolbecker AR, Howell J, Rass O, Sporns O, Hetrick WP et al. Disturbed resting state EEG synchronization in bipolar disorder: a graph-theoretic analysis. Neuroimage Clin 2013; 2: 414-423.
42. Ongur D, Lundy M, Greenhouse I, Shinn AK, Menon V, Cohen BM et al. Default mode network abnormalities in bipolar disorder and schizophrenia. Psychiatry Res 2010; 183: 59-68.
43. Disner SG, Beevers CG, Haigh EA, Beck AT. Neural mechanisms of the cognitive model of depression. Nat Rev Neurosci 2011; 12: 467-477.
44. Maren S. Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci 2001; 24: 897-931.
45. Maren S. Pavlovian fear conditioning as a behavioral assay for hippocampus and amygdala function: cautions and caveats. Eur J Neurosci 2008; 28: 1661-1666.
46. McGaugh JL. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 2004; 27: 1-28.
47. Phelps EA, LeDoux JE. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005; 48: 175-187.
48. Ehrlich I, Humeau Y, Grenier F, Ciocchi S, Herry C, Luthi A. Amygdala inhibitory circuits and the control of fear memory. Neuron 2009; 62: 757-771.
49. Sweeney FF, O'Leary OF, Cryan JF. GABAB receptor ligands do not modify conditioned fear responses in BALB/c mice. Behav Brain Res 2013; 256: 151-156.
50. Li X, Risbrough VB, Cates-Gatto C, Kaczanowska K, Finn MG, Roberts AJ et al. Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice. Neuropharmacology 2013; 70: 156-167.
51. Heaney CF, Bolton MM, Murtishaw AS, Sabbagh JJ, Magcalas CM, Kinney JW. Baclofen administration alters fear extinction and GABAergic protein levels. Neurobiol Learn Mem 2012; 98: 261-271.
52. Beenhakker MP, Huguenard JR. Astrocytes as gatekeepers of GABAB receptor function. J Neurosci 2010; 30: 15262-15276.
53. Yu SP, Yeh CH, Sensi SL, Gwag BJ, Canzoniero LM, Farhangrazi ZS et al. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 1997; 278: 114-117.